Rodeo Therapeutics

About:

Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.

Website: http://rodeotherapeutics.com/

Top Investors: Eli Lilly, AbbVie, Alexandria Venture Investments, ARCH Venture Partners, WuXi AppTec

Description:

Rodeo Therapeutics is a drug development company focused on novel enzyme target and biological pathway that play a critical role in tissue repair and regeneration. Rodeo’s initial goal is to develop novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.

Total Funding Amount:

$14.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)rodeotherapeutics.com

Founders:

Joseph Ready, Sanford Markowitz, Stanton Gerson

Number of Employees:

1-10

Last Funding Date:

2018-11-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai